Research ArticleBasic Science Investigations
Claudin-4 SPECT Imaging Allows Detection of Aplastic Lesions in a Mouse Model of Breast Cancer
Michael Mosley, James Knight, Albrecht Neesse, Patrick Michl, Manuela Iezzi, Veerle Kersemans and Bart Cornelissen
Journal of Nuclear Medicine May 2015, 56 (5) 745-751; DOI: https://doi.org/10.2967/jnumed.114.152496
Michael Mosley
1CR-UK/MRC Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, United Kingdom
James Knight
1CR-UK/MRC Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, United Kingdom
Albrecht Neesse
2Department of Gastroenterology II, University Medical Center, Georg-August University, Göttingen, Germany
Patrick Michl
3Department of Gastroenterology, Endocrinology, Infectiology and Metabolism, Philipps University Marburg, Marburg, Germany; and
Manuela Iezzi
4Department of Medicine and Aging Sciences, G. d'Annunzio University of Chieti-Pescara, Chieti, Italy
Veerle Kersemans
1CR-UK/MRC Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, United Kingdom
Bart Cornelissen
1CR-UK/MRC Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, United Kingdom
In this issue
Journal of Nuclear Medicine
Vol. 56, Issue 5
May 1, 2015
Claudin-4 SPECT Imaging Allows Detection of Aplastic Lesions in a Mouse Model of Breast Cancer
Michael Mosley, James Knight, Albrecht Neesse, Patrick Michl, Manuela Iezzi, Veerle Kersemans, Bart Cornelissen
Journal of Nuclear Medicine May 2015, 56 (5) 745-751; DOI: 10.2967/jnumed.114.152496
Jump to section
Related Articles
Cited By...
- Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer
- Creation of a Claudin-2 Binder and Its Tight Junction-Modulating Activity in a Human Intestinal Model
- Claudin-5-Binders Enhance Permeation of Solutes across the Blood-Brain Barrier in a Mammalian Model
- Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker
- Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells